Cargando…
CD26 is a senescence marker associated with reduced immunopotency of human adipose tissue-derived multipotent mesenchymal stromal cells
INTRODUCTION: Human mesenchymal stromal cells (MSCs) have immunomodulatory, anti-inflammatory, and tolerogenic effects. Long-term in vitro expansion of MSCs to generate clinical grade products results in the accumulation of senescent-functionally impaired MSCs. Markers to assess the ‘senescent load’...
Autores principales: | Psaroudis, Rose Triantafillia, Singh, Urvashi, Lora, Maximilien, Jeon, Peter, Boursiquot, Abigail, Stochaj, Ursula, Langlais, David, Colmegna, Inés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327293/ https://www.ncbi.nlm.nih.gov/pubmed/35883188 http://dx.doi.org/10.1186/s13287-022-03026-4 |
Ejemplares similares
-
A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis
por: Kizilay Mancini, Özge, et al.
Publicado: (2017) -
Optimized reagents for immunopotency assays on mesenchymal stromal cells for clinical use
por: Torrents, Sílvia, et al.
Publicado: (2023) -
Human multipotent mesenchymal stromal cells cytokine priming promotes RAB27B-regulated secretion of small extracellular vesicles with immunomodulatory cargo
por: Cheng, Anastasia, et al.
Publicado: (2020) -
MSC - targets for atherosclerosis therapy
por: Colmegna, Ines, et al.
Publicado: (2018) -
Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression
por: Kizilay Mancini, Ozge, et al.
Publicado: (2015)